Navigation Links
Synova Acquires Rights to Today Sponge Contraceptive, Plans Advertising Campaign

Synova Healthcare on Wednesday after purchasing New Jersey-based Allendale Pharmaceuticals, which markets the female contraceptive Today Sponge, //announced plans to begin an aggressive campaign to market the product, the Philadelphia Inquirer reports (Loyd, Philadelphia Inquirer, 1/17).

The Today Sponge, which is constructed of soft polyurethane foam and is inserted into the vagina for up to 24 hours, provides barrier protection and the spermicide nonoxynol-9 to prevent pregnancy. The device is 89% to 91% effective in preventing pregnancy but does not protect against sexually transmitted infections.

The sponge was introduced in 1983, but sale of the product was discontinued in 1995 because its manufacturer, Whitehall-Robbins -- now known as Wyeth -- did not want to invest in the equipment upgrades necessary to maintain FDA approval. Allendale in 2000 purchased the manufacturing rights to the sponge, and FDA approved it in April 2005.

The Today Sponge had sales of about 250 million from 1983 through 1995 (Kaiser Daily Women's Health Policy Report, 4/25/05). According to Synova, the product costs about $7.99 for a three-pack. Synova plans to begin an aggressive marketing campaign to inform consumers that 'the sponge is back,' Synova CEO Stephen King said.

The first 120 days of the campaign will focus on public relations and Internet advertisements and will be followed by television, radio and print advertisements in May, King said.

He added that the company will target members of the 'ob-gyn community' who are 'unaware this product is back.' Allendale will operate as a subsidiary of Synova and will continue to manufacture the Today Sponge, the Inquirer reports (Philadelphia Inquirer, 1/17).

Source: Kaiser Family Foundation
SRI
'"/>




Page: 1

Related medicine news :

1. Ossur Acquires the U.S. Orthopaedics Company
2. Stem of Hope: Stem Cell Research Acquires a Brittle Star As A model
3. Pfizer Acquires Worldwide Rights For New Overactive Bladder Drug
4. Premier Army Hospital Acquires PET-CT Scanner
5. Indoco Remedies Acquires La Nova Chem
6. Ranbaxy Acquires Glaxosmithklines Generic Unit in Spain
7. AIIMS Acquires Four-Armed Robot to Assist in Surgeries
8. Apollos Global Arm Acquires US-based Firm
9. ‘Obesity’ Acquires Permanent Resident Status in the US
10. Indias Wockhardt Acquires Irish Firm
11. Battle against Gum Disease Acquires new Weapon
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... , ... March 23, 2017 , ... ... audit software solution, iCode Assurance, at HCCA’s 21st annual Compliance Institute on March ... the coding audit process for all medical chart types with a comprehensive set ...
(Date:3/23/2017)... ... , ... “Wounded Woman Be Ye Healed-Passing On A Legacy”: a call to ... the creation of published author, Desiree M Webb, a registered nurse, minister of music, ... happily married to her husband, Paul, for over twenty-nine years. Desiree enjoys writing, ...
(Date:3/23/2017)... ... March 23, 2017 , ... “A Respectful Response To Atheist ... To Atheist Manifesto” is the creation of published author Richard Hostetter, a former ... years. He holds graduate degrees from Kent State University and the University of ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... ... today announced the publication of “Profiling protein expression in circulating tumor cells using ... publication describes the use of the Vortex technology to capture CTCs ...
(Date:3/22/2017)... ... 2017 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had won the ‘Clinical Supply Chain Excellence’ category ... International Exhibition & Convention Centre, Singapore. The award was presented at the conference ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... Inc. today announced the appointment of Martyn Coombs as ... of ImaginAb, said "At ImaginAb we have exciting science and technology. ... our business, particularly in commercializing and making step changes in the ... realize our potential." ... Mr. Coombs is a recognized industry leader in nuclear medicine and ...
(Date:3/22/2017)... N.J. , March 22, 2017  CANTEL MEDICAL CORP. ... B. Hansen , President and CEO, will be presenting at ... at the Westin Grand Central Hotel in New ... April 5, 2017 at 3:00 p.m. ET. In addition, management ... A live audio webcast will be available ...
(Date:3/22/2017)... 22, 2017 Research and Markets has ... Inhibitors Market & Clinical Pipeline Insight 2022" drug pipelines ... ... Clinical Pipeline Insight 2022 report gives comprehensive insight on clinical ... immune check point inhibitors as main streamline drugs in the ...
Breaking Medicine Technology: